Video

Dr. Weber discusses cardiovascular safety of vibegron in patients with OAB

“The take-home message is vibegron is a very safe drug and there are no concerns about any kind of cardiovascular adverse effects,” says Michael A. Weber, MD.

In this video, Michael A. Weber, MD, discusses the takeaways of the study, “Effects of vibegron on ambulatory blood pressure in patients with overactive bladder: results from a double-blind study,” presented at the 2021 American Urological Association Annual Meeting. Weber is a professor of medicine and associate dean of research at Downstate College of Medicine, State University of New York, Brooklyn, New York.

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Dean S. Elterman, MD, MSc, FRCSC, answers a question during a Zoom video interview
Vanita Gaglani, RPT, answers a question during a video interview
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
© 2025 MJH Life Sciences

All rights reserved.